SOUTH EAST ASIA AND SOUTH ASIA INDUSTRIAL MICROBIOLOGY MARKET ANALYSIS

South East Asia And South Asia Industrial Microbiology Market, By Product Type (Equipment & System (Filtration Pumps & Systems, Microbial Detection Systems, Air Monitoring Systems, Incubators & Culture apparatus, Others), Reaction Consumables (Media (Simple Media, Complex Media, Defined Media, and Specialty Media), Reagents & Stains, and Others), Laboratory Supply (Bags & Bottles, Loop & Needles, Petrifies, Racks, Seals, Plates & Holders, Sample preparation & Collection, Filtration Discs, Membranes, Others)), By Testing Type (Sterility Testing (Open System, Closed System, RTU Bottles, DCM), Bio-burden Testing (Membrane, Funnels), Environmental Testing(RTU Plates, DCM, Hygiene Monitoring in Food, Air samplers, Compressed Gas Monitoring), Pyrogen Testing, Pathogen Testing, Traditional Method (Rapid (Platform), Others)), By End User (Pharmaceuticals & Biotechnology Industry, Government, Academia, Food and Beverage Industry, Testing Labs/Commercial Labs, Others), By Geography (South East Asia And South Asia)

Published In : Mar 2025
Code : CMI4411
Pages :210
Formats :
Excel and PDF
Industry : Biotechnology

Market News

South East Asia and South Asia Industrial Microbiology Market: Key Developments

On June 29, 2023, Merck KGaA, a leading science and technology company, announced that it had invested US$ 70 Mn for expanding production capacity for highly-purified reagents at its site in Nantong, China, to overcome increased demand for high-quality products and a more resilient supply chain.
On May 03, 2023, MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, a leading science and technology company, announced that the Life Science business sector had signed a non-binding Memorandum of Understanding (MoU) with the Ministry of Trade, Industry and Energy (MOTIE), and Daejeon City, India for a new Asia Pacific BioProcessing Center, aimed at supporting the region’s healthcare eco-system. The planned bioprocessing facility would support commercial manufacturing for biotech and pharmaceutical customers across Asia Pacific.
In June 2022, STEMart, a provider of integrated medical device and diagnostic clinical development, introduced comprehensive microbiology and sterility testing for sterile and non-pyrogenic products. STEMart has extensive expertise in microbiology as well as sterility testing and remains dedicated to a full-service experience that supports manufacturers in meeting regulatory goals and minimizing compliance risk.
In April 2022, Hygiena LLC, a microbiology and life science company, launched a new, ultra-rapid, microbial screening kit named RapiScreen Beverage Kit that provides high-performance testing for low pH beverages using Innovate System. The kit provides quality control results in less than 30 minutes following a preliminary incubation period, allowing manufacturers to confirm product quality for quick release to market.
In May 2021, Thermo Fisher Scientific Inc., a biotechnology company, launched first-in-market CO₂ incubator that combines optimal cell growth capabilities with certified cleanroom compatibility, and thus, effectively addressing the growing need among biotechnology, biopharmaceutical, and clinical laboratories for high-performance incubation systems that meet stringent cleanroom and cGMP standards.
In March 2021, PHC Holdings Corporation, a biotechnology company, launched New IncuSafe Cell Culture Incubators MCO-50AIC & MCO-50M to provide precise control of CO₂ concentrations and accurate, uniform, and highly responsive temperature control within the chamber.